Galway consortium awarded €4m to develop world’s first wireless digital stent platform
A consortium consisting of Galway firm ÉireComposites, University of Galway and OpenText has received €4 million from Enterprise Ireland under the DTIF Call 6 to develop DigiStent, a wireless digital medical device that aims to predict device failure in abdominal aorta stent patients.
Abdominal aortic aneurysms have an 80-90% risk of immediate death if ruptured. A frequently used treatment is Endovascular Aneurysm Repair, which involves the insertion of a stent. However, this solution suffers a failure rate of roughly 30%. DigiStent is an AI-driven solution providing patient and doctor with continuous dynamic monitoring of the inserted stent.
Leveraging intellectual property in novel materials and manufacturing, AI-based analytics, and bio-sensor modelling and integration, the DigiStent team will develop the world’s first wireless digital stent platform with greater then 95% data accuracy.
On a national and international scale, the project will have incredible impacts. It is set to run over the course of three years and is highly aligned to several National Strategic Objectives. DigiStent directly aligns with the Government of Ireland’s Research Priority Areas 2018-2023, prioritising health and medical devices, as well as UN Sustainable Development Goal 3 – ensuring healthy lives and promoting well-being for all.
TechCentral Reporters
Subscribers 0
Fans 0
Followers 0
Followers